Seattle Genetics/ US81181C1045 /
12/13/2023 10:19:51 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
228.86USD | - | 577,731 Turnover: 132.25 mill. |
-Bid Size: - | -Ask Size: - | 43.15 bill.USD | - | - |
Assets
|
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 103.8000 | 155.4910 | 196.7000 | 210.0730 | 248.1790 | ||||||
Intangible Assets | 0.0000 | - | 283.6800 | 260.5930 | 237.5160 | ||||||
Long-Term Investments | - | 57.2830 | 100.8300 | 0.0000 | - | ||||||
Fixed Assets | - | 1,029.2250 | 938.5220 | 850.4100 | 871.9990 | ||||||
Inventories | 53.2000 | 85.9320 | 116.1360 | 200.6630 | 427.2110 | ||||||
Accounts Receivable | 146.3000 | 236.0010 | 324.9880 | 389.2560 | 501.9120 | ||||||
Cash and Cash Equivalents | 78.2000 | 274.5620 | 558.4240 | 424.8340 | 319.9400 | ||||||
Current Assets | 653.6000 | 1,176.6410 | 3,062.3840 | 2,869.1940 | 2,802.5330 | ||||||
Total Assets | 1,503.3000 | 2,205.8660 | 4,000.9060 | 3,719.6040 | 3,674.5320 |
Liabilities
|
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 44.2000 | 52.2920 | 78.0670 | 114.8240 | 207.8510 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | - | - | - | - | - | ||||||
Liabilities | 229.4000 | 329.5790 | 512.8060 | 654.4650 | 870.7130 | ||||||
Share Capital | .1600 | .1720 | .1810 | .1830 | .1870 | ||||||
Total Equity | 1,273.9000 | 1,876.2870 | 3,488.1000 | 3,065.1390 | 2,803.8190 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 1,503.3000 | 2,205.8660 | 4,000.9060 | 3,719.6040 | 3,674.5320 |
Income Statement
|
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 654.7000 | 916.7130 | 2,175.5360 | 1,574.3710 | 1,962.4120 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -260 | -220.5450 | 596.8520 | -682.0560 | -612.9700 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | -246.3000 | - | 615.7010 | -675.7050 | -602.3150 | ||||||
Income Taxes | -23.7000 | 0.0000 | -2 | -1.2000 | 8 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | -222.7000 | -158.6500 | 613.6700 | -674.4710 | -610.3080 |
Per Share
Cash Flow
|
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -203.5000 | -163.7370 | 856.5680 | -499.0070 | -453.7510 | ||||||
Cash Flow from Investing Activities | -592.6000 | -277.7290 | -1,419.0120 | 288.8840 | 228.2370 | ||||||
Cash Flow from Financing | 713.4000 | 637.8420 | 846.1080 | 77.7790 | 125.3600 | ||||||
Decrease / Increase in Cash | -82.8000 | 196.3760 | 283.8620 | -133.5900 | -101.3480 | ||||||
Employees | 1,302 | 1,605 | 2,092 | 2,675 | 3,256 |